A. Laszlo et al., CLINICAL ASPECTS OF UPPER GASTROINTESTINAL-BLEEDING ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS, The American journal of gastroenterology, 93(5), 1998, pp. 721-725
Objective: The aim of this study was to compare the clinical features
of major upper gastrointestinal bleeding among patients exposed to non
steroidal antiinflammatory drugs (NSAID) and those not taking these dr
ugs. Methods: Using data from a multicenter international case-control
study designed to evaluate the role of drugs in the etiology of major
upper gastrointestinal bleeding (UGIB), patients with a confirmed fir
st episode of major UGIB were divided into two groups: those exposed t
o NSAIDs during the week before the onset of bleeding, and those not e
xposed. The groups were compared according to age and sex, clinical ap
pearance and site of the bleeding, preceding symptoms, and requirement
for transfusion and acute surgery. Results: The median age was signif
icantly higher and the proportion of women was slightly higher among t
he NSAID users. There was no significant difference between users and
nonusers according to the clinical presentation, the site of the bleed
ing, or the frequency of preceding symptoms. Forty percent in each gro
up had no symptoms before the onset of bleeding. Slightly more NSAID u
sers received blood transfusions, although the same median amount of b
lood per transfusion was given in both groups. There was no difference
in the frequency of surgical intervention. Conclusions: There are no
important differences in the clinical presentation of major UGIB accor
ding to whether or not an individual is an NSAID user. An important fi
nding is the frequent absence of preceding symptoms in patients with m
ajor UGIB, regardless of NSAID use. (C) 1998 by Am. Coll. of Gastroent
erology.